Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:CNABOTCMKTS:MNTROTCMKTS:PKPHOTCMKTS:PVSP On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCNABUnited Cannabis$0.00$0.02▼$0.78$1.55MN/A730,433 shs7.53 million shsMNTRMentor Capital$0.05-4.9%$0.05$0.03▼$0.11$1.12M-0.7213,946 shs3,837 shsPKPHPeak Pharmaceuticals$1.08+6.1%$2.05$0.52▼$9.12$423K0.549,053 shs360 shsPVSPPervasip$0.00$0.00$0.00▼$0.00$1.09M-0.415.57 million shs316,050 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCNABUnited Cannabis0.00%0.00%0.00%0.00%0.00%MNTRMentor Capital-4.85%-5.22%-7.89%+18.36%-12.50%PKPHPeak Pharmaceuticals0.00%+8.00%+33.02%-72.31%-50.91%PVSPPervasip0.00%0.00%-33.33%0.00%-33.33%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCNABUnited CannabisN/AN/AN/AN/AN/AN/AN/AN/AMNTRMentor CapitalN/AN/AN/AN/AN/AN/AN/AN/APKPHPeak PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/APVSPPervasipN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCNABUnited Cannabis 0.00N/AN/AN/AMNTRMentor Capital 0.00N/AN/AN/APKPHPeak Pharmaceuticals 0.00N/AN/AN/APVSPPervasip 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCNABUnited CannabisN/AN/AN/AN/AN/AN/AMNTRMentor Capital$7.71M0.14N/AN/A$0.13 per share0.38PKPHPeak PharmaceuticalsN/AN/AN/AN/AN/AN/APVSPPervasip$15.77M0.07N/AN/AN/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCNABUnited CannabisN/AN/A0.00N/AN/AN/AN/AN/AN/AMNTRMentor Capital-$840K-$0.04N/A∞N/AN/A-28.51%-24.14%N/APKPHPeak Pharmaceuticals-$160KN/A0.00∞N/AN/AN/A-159.55%N/APVSPPervasip$16.92MN/A0.00∞N/AN/A-11.27%26.60%N/ALatest PKPH, CNAB, PVSP, and MNTR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025MNTRMentor CapitalN/A-$0.01N/A-$0.01N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCNABUnited CannabisN/AN/AN/AN/AN/AMNTRMentor CapitalN/AN/AN/AN/AN/APKPHPeak PharmaceuticalsN/AN/AN/AN/AN/APVSPPervasipN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCNABUnited CannabisN/AN/AN/AMNTRMentor CapitalN/A17.5917.59PKPHPeak PharmaceuticalsN/A0.150.15PVSPPervasipN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCNABUnited CannabisN/AMNTRMentor CapitalN/APKPHPeak PharmaceuticalsN/APVSPPervasipN/AInsider OwnershipCompanyInsider OwnershipCNABUnited CannabisN/AMNTRMentor Capital23.73%PKPHPeak Pharmaceuticals18.40%PVSPPervasip9.20%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCNABUnited Cannabis6593.73 millionN/ANot OptionableMNTRMentor Capital221.69 million16.54 millionNot OptionablePKPHPeak Pharmaceuticals1392,000320,000Not OptionablePVSPPervasip35.43 billion4.93 billionNot OptionablePKPH, CNAB, PVSP, and MNTR HeadlinesRecent News About These CompaniesPervasip Announces First Quarter FinancialsApril 23, 2024 | globenewswire.comPervasip Announces Financial Results for Fiscal Year 2023February 29, 2024 | globenewswire.comPervasip Announces Successful Completion of Pcaob AuditJanuary 27, 2024 | finance.yahoo.comPervasip Announces Third Quarter FinancialsOctober 17, 2023 | finance.yahoo.comPervasip Announces Second Quarter FinancialsJuly 18, 2023 | finance.yahoo.comPervasip Announces Expansion Into California MarketJune 29, 2023 | finance.yahoo.comPERVASIP ANNOUNCES FIRST OREGON ARTIZEN TOP-SHELF FLOWER HARVESTS FOR AUGUSTJune 20, 2023 | finance.yahoo.comPERVASIP ANNOUNCES ENTRY INTO $1.1B OREGON RECREATIONAL CANNABIS MARKETApril 19, 2023 | finance.yahoo.comPervasip Announces First Quarter FinancialsApril 17, 2023 | finance.yahoo.comPervasip is Entering the $8 Billion Global Nano Market With Artizen Nano and Acquires SlurpedApril 5, 2023 | finance.yahoo.comPervasip Announces Financial Results for Fiscal Year 2022March 1, 2023 | finance.yahoo.comPervasip Announces Artizen Spin OffJanuary 17, 2023 | finance.yahoo.comPervasip Announces 3rd Quarter FinancialsOctober 18, 2022 | finance.yahoo.comPervasip Q3 Revenue Grows 17% Sequentially, Here Are The DetailsOctober 18, 2022 | benzinga.comPervasip Announces Strategic Acquistion and $4 Million in New RevenuesOctober 10, 2022 | finance.yahoo.comPervasip Announces $1.6 Million in August Revenues and 3rd Quarter GuidanceSeptember 13, 2022 | finance.yahoo.com24 MONTH ROADMAP TO $50 MILLION IN SALESSeptember 6, 2022 | finance.yahoo.comRestructuring Leading to $500,000 in Annual Cost Savings Plus New Customer ContractsAugust 4, 2022 | finance.yahoo.comArtizen Succesfully Launched New Product LineJuly 28, 2022 | finance.yahoo.comPervasip Announces 2 Billion Authorized Share Reduction and no Reverse Splits for 5 YearsJuly 21, 2022 | finance.yahoo.comNew MarketBeat Followers Over TimePKPH, CNAB, PVSP, and MNTR Company DescriptionsUnited Cannabis OTCMKTS:CNABUnited Cannabis Corporation owns intellectual properties related to growth, production, manufacture, marketing, management, utilization, and distribution of medical marijuana and marijuana infused products in the United States. The company focuses on developing therapeutics, including Prana Bio Nutrient Medicinal products for supplement deficiencies related to the endocannabinoid system, including pain, neuropathy, arthritis, MS, IBS, autism, seizures, eczema, sleep, anxiety, head trauma, opioid dependency, and clinical endocannabinoid deficiencies; and Prana Aromatherapy Transdermal Roll-on line that provides targeted and large surface relief with combinations of aromatherapy. The company was formerly known as MySkin, Inc. and changed its name to United Cannabis Corporation in May 2014. United Cannabis Corporation was founded in 2007 and is based in Golden, Colorado.Mentor Capital OTCMKTS:MNTR$0.05 0.00 (-4.85%) As of 07/3/2025 12:44 PM EasternMentor Capital, Inc. is a private equity firm specializing in acquisitions and emerging growth investments. The firm provides passive equity funding and liquidity to smaller companies and owners in the medical, marijuana and social use cannabis companies. It invests in shelf IPO's and public and private companies and seeks to provide public market access to owners of small private companies. The firm specializes in pre-IPO investments in Cannabis companies. It seeks to invest in energy sector of oil and gas, coal, uranium. In case of shelf IPO's, the firm prefers to invest in companies with sales greater than $40 million. It prefers to take significant position in its portfolio companies. The firm invests only in companies that have earnings. Mentor Capital, Inc. was founded in 1985 and is based in Plano, Texas.Peak Pharmaceuticals OTCMKTS:PKPH$1.08 +0.06 (+6.14%) As of 06/30/2025Peak Pharmaceuticals, Inc. manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.Pervasip OTCMKTS:PVSP$0.0002 0.00 (0.00%) As of 07/2/2025 03:01 PM EasternPervasip Corporation focuses on developing cloud-based applications to monitor and control greenhouse facilities. It intends to develop and deliver products and technologies to agricultural markets; develop scientific methods for the analysis of cannabinoids in flowers, concentrates, and edibles; and assist medical marijuana specialty production facilities to regulate, calculate proper dosage, and understand the importance of consistency in product. The company was formerly known as eLEC Communications Corp. and changed its name to Pervasip Corp. in December 2007. Pervasip Corp. was founded in 1964 and is based in White Plains, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Why Occidental's Price Dip Signals a Buying Opportunity Rigetti Computing: Cantor's Bullish Call May Be Just the Start Insider Selling at NVIDIA Could Turn Into an Opportunity Whiplash for Investors: AeroVironment's Confusing Stock Signals Rocket Lab: Latest Catalysts Bolster the Bull Case Nike's Stock Just Got an Upgrade: Is a Real Comeback Brewing? Why Hims & Hers Is a Buy Below $35 After Its 16% Pullback Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
